Skip to content
BidBenchmark

Contract award

REGENERON PHARMACEUTICALS INC

IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
PIID
HHSO100201700020C
Award key
CONT_AWD_HHSO100201700020C_7505_-NONE-_-NONE-
Recipient UEI
N3F9MH7E6HD6
Source as of
—
Current award value
$278,844,1723
Obligated to date
$278,844,1722
Potential with options
$359,611,7583
Awarding agency
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
Place of performance
Tarrytown, New York
Set-aside
No set-aside used
Pricing
Cost Sharing
Competition
Full and Open Competition1 offers received
Period of performance
Sep 21, 2017 — Sep 25, 2027Through Sep 25, 2027 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 21, 2017Initial award$18,693,213.00$278,844,171.83
1Sep 21, 2018B$0.00$278,844,171.83
P00002Mar 31, 2019M$0.00$278,844,171.83
P00003Sep 12, 2019D$19,552,893.00$278,844,171.83
P00004Jan 31, 2020D$5,751,859.00$278,844,171.83
P00005Feb 14, 2020M$0.00$278,844,171.83
P00006Mar 21, 2020D$92,984,806.00$278,844,171.83
P00007Apr 29, 2020C$9,247,916.00$278,844,171.83
P00008Jun 15, 2020D$85,094,597.00$278,844,171.83
P00009Jun 18, 2020B$53,517,946.00$278,844,171.83
P00010May 28, 2021M$0.00$278,844,171.83
P00011Jun 30, 2022B$0.00$278,844,171.83
P00012Aug 21, 2023M$326,475,498.00$278,844,171.83
P00013Nov 13, 2023M$0.00$278,844,171.83
P00014Dec 14, 2023M$0.00$278,844,171.83
P00015Dec 5, 2024B$0.00$278,844,171.83
P00016Aug 8, 2025M-$331,708,160.10$278,844,171.83
P00017Sep 16, 2026B-$766,396.07$278,844,171.83

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.gov—Sep 22, 2026usaspending_contract_csv@2026.08.24f9981988b3e
contractor_idUSAspending.gov—Sep 22, 2026usaspending_contract_csv@2026.08.24f9981988b3e
current_award_valueUSAspending.gov—Sep 22, 2026usaspending_contract_csv@2026.08.24f9981988b3e
naics_codeUSAspending.gov—Sep 22, 2026usaspending_contract_csv@2026.08.24f9981988b3e
potential_award_valueUSAspending.gov—Sep 22, 2026usaspending_contract_csv@2026.08.24f9981988b3e
psc_codeUSAspending.gov—Sep 22, 2026usaspending_contract_csv@2026.08.24f9981988b3e
total_obligatedUSAspending.gov—Sep 22, 2026usaspending_contract_csv@2026.08.24f9981988b3e

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 18 transaction records parsed from USAspending.gov, retrieved Sep 22, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
HHSO100201700020C — REGENERON PHARMACEUTICALS INC · BidBenchmark